Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study.

Clinical trial NCT01467518 · COMPLETED

Trial details

NCT number: NCT01467518
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infections, Human Immunodeficiency Virus and Hepatitis

Start date: 2011-12-01
Primary completion: 2012-02-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.